Bellus Health

Science

Scientific Publications

  • BLU-5937; A Potent and Selective P2X3 Antogonist, for the Treatment of Chronic Itch: Evidence from Preclinical Studies. 2019 European Society for Dermatological Research Conference.
    Read More
  • BLU-5937: A Highly Selective P2X3 Homotrimeric Receptor Antagonist, Exhibits Excellent Pharmacokinetic and Safety Profile Including Improved Taste Safety Profile in Healthy Subjects. 2019 American Cough Conference.
    Read More
  • BLU-5937 a Highly Selective P2X3 Homotrimeric Receptor Antagonist with Improved Taste Safety Profile in Healthy Subjects. 2019 American Thoracic Society Conference.
    Read More
  • BLU-5937: A selective P2X3 antagonist with potent anti-tussive effect and no taste alteration. ELSEVIER.
    Read More